中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Novel kappa-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation

文献类型:期刊论文

作者Zhang, Le-sha2,3; Wang, Jun2,3,4; Chen, Jian-chun1; Tao, Yi-min2,3; Wang, Yu-hua4,5; Xu, Xue-jun2,3; Chen, Jie2,3; Xu, Yun-gen4; Xi, Tao4; Hu, Xiao-wu1
刊名ACTA PHARMACOLOGICA SINICA
出版日期2015-05
卷号36期号:5页码:565-571
关键词kappa-opioid receptor MB-1C-OH (-)U50,488H Nor-BNI morphine pain acetic acid-induced writhing formalin test depression sedation
ISSN号1671-4083
DOI10.1038/aps.2014.145
文献子类Article
英文摘要Aim: To characterize the pharmacological profiles of a novel kappa-opioid receptor agonist MB-1C-OH. Methods: [H-3]diprenorphine binding and [S-35]GTP.S binding assays were performed to determine the agonistic properties of MB-1C-OH. Hot plate, tail flick, acetic acid-induced writhing, and formalin tests were conducted in mice to evaluate the antinociceptive actions. Forced swimming and rotarod tests of mice were used to assess the sedation and depression actions. Results: In [H-3]diprenorphine binding assay, MB-1C-OH did not bind to mu- and delta-opioid receptors at the concentration of 100 mu mol/L, but showed a high affinity for kappa-opioid receptor (kappa(i)=35 nmol/L). In [S-35]GTP gamma S binding assay, the compound had an E-max of 98% and an EC50 of 16.7 nmol/L for kappa-opioid receptor. Subcutaneous injection of MB-1C-OH had no effects in both hot plate and tail flick tests, but produced potent antinociception in the acetic acid-induced writhing test (ED50= 0.39 mg/kg), which was antagonized by pretreatment with a selective.-opioid receptor antagonist Nor-BNI. In the formalin test, subcutaneous injection of MB-1C-OH did not affect the flinching behavior in the first phase, but significantly inhibited that in the second phase (ED50=0.87 mg/kg). In addition, the sedation or depression actions of MB-1C-OH were about 3-fold weaker than those of the classical kappa agonist (-)U50,488H. Conclusion: MB-1C-OH is a novel kappa-opioid receptor agonist that produces potent antinociception causing less sedation and depression.
WOS关键词FORMALIN TEST ; BEHAVIOR ; RATS ; MU ; ACTIVATION ; MORPHINE ; BINDING ; PAIN ; MICE ; DEPENDENCE
资助项目National Basic Research Program: a grant from the Ministry of Science and Technology of China[2009CB522005] ; National Natural Science Foundation of China[81130087] ; National Natural Science Foundation of China[81171296]
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
CSCD记录号CSCD:5425430
WOS记录号WOS:000353893100004
出版者ACTA PHARMACOLOGICA SINICA
源URL[http://119.78.100.183/handle/2S10ELR8/276553]  
专题药理学第二研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Wang, Yu-jun
作者单位1.Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
3.Chinese Acad Sci, Collaborat Innovat Ctr Brain Sci, Shanghai 201203, Peoples R China;
4.China Pharmaceut Univ, Sch Life Sci & Technol, Biotechnol Ctr, Nanjing 210009, Peoples R China;
5.Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210046, Jiangsu, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Le-sha,Wang, Jun,Chen, Jian-chun,et al. Novel kappa-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation[J]. ACTA PHARMACOLOGICA SINICA,2015,36(5):565-571.
APA Zhang, Le-sha.,Wang, Jun.,Chen, Jian-chun.,Tao, Yi-min.,Wang, Yu-hua.,...&Liu, Jing-gen.(2015).Novel kappa-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.ACTA PHARMACOLOGICA SINICA,36(5),565-571.
MLA Zhang, Le-sha,et al."Novel kappa-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation".ACTA PHARMACOLOGICA SINICA 36.5(2015):565-571.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。